Cargando…

Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease

BACKGROUND: Forced vital capacity (FVC) has been suggested to be a good biomarker for decreased exercise performance in patients with chronic obstructive pulmonary disease (COPD). However, as FVC is highly correlated with forced expiratory volume in 1 second (FEV(1)), the relationship between FVC an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Seong Mi, Lim, Jun Hyeok, Hong, Yun Soo, Shin, Kyeong-Cheol, Lee, Chang Youl, Kim, Do Jin, Lee, Sang Haak, Jung, Ki Suck, Lee, Chang-Hoon, Yoo, Kwang Ha, Lee, Hyun, Park, Hye Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947547/ https://www.ncbi.nlm.nih.gov/pubmed/33717557 http://dx.doi.org/10.21037/jtd-20-1098a

Ejemplares similares

Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity
por: Choi, Joon Young, et al.
Publicado: (2023)

Correlation between Forced Vital Capacity and the Severity of Frailty-Induced Dysphagia
por: Lee, Byung Joo, et al.
Publicado: (2022)

Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke
por: Cho, Jaeyoung, et al.
Publicado: (2019)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
por: Kim, Junghyun, et al.
Publicado: (2017)

Determinants of Nicotine Dependence in Chronic Obstructive Pulmonary Disease
por: Sim, Yun Su, et al.
Publicado: (2017)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
por: Lee, Sang Haak, et al.
Publicado: (2021)

Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Nam Eun, et al.
Publicado: (2023)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition
por: Choi, Joon Young, et al.
Publicado: (2019)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Heock, et al.
Publicado: (2016)

Reduced forced vital capacity is associated with cerebral small vessel disease burden in cognitively normal individuals
por: Kim, Yeshin, et al.
Publicado: (2019)

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Difference between slow vital capacity and forced vital capacity in the diagnosis of airflow limitation
por: Pereira, Carlos Alberto de Castro
Publicado: (2020)

Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study
por: Cho, Jaeyoung, et al.
Publicado: (2020)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Effects of pelvic tilt angles and forced vital capacity in healthy individuals
por: Hwang, Young-In, et al.
Publicado: (2018)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
por: Zhang, Xiaoling, et al.
Publicado: (2020)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Successful Surgery for Scoliosis Supported by Pulmonary Rehabilitation in a Duchenne Muscular Dystrophy Patient With Forced Vital Capacity Below 10%
por: Lee, Jang Woo, et al.
Publicado: (2013)

Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity
por: Obi, Ogugua Ndili
Publicado: (2023)

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern
por: Khalid, Imran, et al.
Publicado: (2011)

Relationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination Survey
por: Kang, Hyung Koo, et al.
Publicado: (2015)

Vitality and the Vital Forces
por: Noel, H. R.
Publicado: (1870)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020)

Pathophysiology of reduced forced vital capacity with airflow obstruction on spirometry: performance of two mathematical models in clinical practice
por: Wong, Bruno de Moraes Santos, et al.
Publicado: (2023)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Association of Forced Vital Capacity with the Developmental Gene NCOR2
por: Minelli, Cosetta, et al.
Publicado: (2016)

Importance of slow vital capacity in the detection of airway obstruction
por: de Barros, Ana Raquel Gonçalves, et al.
Publicado: (2013)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Which GOLD B patients progress to GOLD D with the new classification?
por: Choi, Hye Sook, et al.
Publicado: (2018)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease
por: Joo, Dong-Hyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nudruck7869j9n1s81ighrp1qv